首页|黄芪对气虚证2型糖尿病患者的临床疗效

黄芪对气虚证2型糖尿病患者的临床疗效

扫码查看
目的 探讨黄芪对气虚证2型糖尿病患者的临床疗效.方法 90例患者随机分为对照组和观察组,每组45例,2组均采用常规治疗,同时对照组给予原治疗方案,观察组在对照组基础上加用黄芪颗粒,疗程12周.检测中医证候疗效和评分、血管内皮功能指标及炎症因子(FMD、NO、ET-1、MHR、CRP)、糖代谢指标(FBG、2 hPBG、HbA1C、FCP)、脂代谢指标(TC、TG、HDL-C、LDL-C)、安全性指标变化.结果 观察组中医证候总有效率高于对照组(P<0.05).治疗后,观察组FMD、NO高于对照组(P<0.05),MHR、2 hPBG、HbA1C、TC、TG及气短、神疲、乏力评分更低(P<0.05).2组未发现明显不良反应.结论 黄芪可安全有效地改善气虚证2型糖尿病患者血管内皮功能障碍,值得临床推广.
Clinical effects of Astragali Radix on patients with type 2 diabetes mellitus of Qi Deficiency Pattern
AIM To explore the clinical effects of Astragali Radix on patients with type 2 diabetes mellitus of Qi Deficiency Pattern.METHODS Ninety patients were randomly assigned into control group (45 cases) for 12-week intervention of both conventional treatment and original treatment regimen,and observation group (45 cases) for 12-week intervention of conventional treatment,original treatment regimen and Astragali Radix granules.The changes in TCM syndrome effects and scores,vascular endothelial function indices and inflammatory cytokines (FMD,NO,ET-1,MHR,CRP),glucose metabolism indices (FBG,2 hPBG,HbA1C,FCP),lipid metabolism indices (TC,TG,HDL-C,LDL-C) and safety indices were detected.RESULTS The observation group demonstrated higher total effective rate of TCM syndromes than the control group ( P<0.05).After the treatment,the observation group displayed higher FMD and NO than the control group (P<0.05),along with lower MHR,2 hPBG,HbA1C,TC,TG and scores for shortness of breath,fatigue,weakness ( P<0.05).No obvious adverse reactions were observable in the two groups.CONCLUSION For the patients with type 2 diabetes mellitus of Qi Deficiency Pattern,Astragali Radix can safely and effectively improve vascular endothelial dysfunction,which is worthy of clinical popularization.

Astragali Radixtype 2 diabetes mellitusQi Deficiency

杨芸艺、杨宏杰、张立娟、陈琳、侯可可、尹宏萍、雷涛、沙雯君

展开 >

上海中医药大学,上海201203

上海中医药大学附属普陀医院,上海200062

上海中医药大学附属岳阳中西医结合医院,上海 200437

上海市普陀区人民医院内分泌科,上海 200061

上海市普陀区卫生健康事务管理中心,上海200063

展开 >

黄芪 2型糖尿病 气虚

2024

中成药
国家食品药品监督管理局,信息中心中成药信息站,上海中药行业协会

中成药

CSTPCD北大核心
影响因子:1.217
ISSN:1001-1528
年,卷(期):2024.46(10)